rs727505067
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_001134363.3(RBM20):c.1816G>A(p.Val606Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000645 in 1,551,488 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001134363.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBM20 | NM_001134363.3 | c.1816G>A | p.Val606Met | missense_variant | Exon 8 of 14 | ENST00000369519.4 | NP_001127835.2 | |
RBM20 | XM_017016103.3 | c.1651G>A | p.Val551Met | missense_variant | Exon 8 of 14 | XP_016871592.1 | ||
RBM20 | XM_017016104.3 | c.1432G>A | p.Val478Met | missense_variant | Exon 8 of 14 | XP_016871593.1 | ||
RBM20 | XM_047425116.1 | c.1432G>A | p.Val478Met | missense_variant | Exon 8 of 14 | XP_047281072.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000383 AC: 6AN: 156514Hom.: 0 AF XY: 0.0000121 AC XY: 1AN XY: 82948
GnomAD4 exome AF: 0.0000536 AC: 75AN: 1399160Hom.: 0 Cov.: 30 AF XY: 0.0000449 AC XY: 31AN XY: 690084
GnomAD4 genome AF: 0.000164 AC: 25AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74486
ClinVar
Submissions by phenotype
Dilated cardiomyopathy 1DD Uncertain:1Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
- -
not specified Uncertain:1
The Val606Met variant in RBM20 has not been previously reported in individuals w ith cardiomyopathy or in large population studies. Computational prediction tool s and conservation analysis suggest that this variant may impact the protein, th ough this information is not predictive enough to determine pathogenicity. Addit ional information is needed to fully assess the clinical significance of the Val 606Met variant. -
not provided Uncertain:1
In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Cardiovascular phenotype Uncertain:1
The p.V606M variant (also known as c.1816G>A), located in coding exon 8 of the RBM20 gene, results from a G to A substitution at nucleotide position 1816. The valine at codon 606 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Cardiomyopathy Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at